Volume 90, Issue 7 , Pages 1102-1109, July 2009
Pulsed Electromagnetic Fields to Reduce Diabetic Neuropathic Pain and Stimulate Neuronal Repair: A Randomized Controlled Trial
Abstract
Weintraub MI, Herrmann DN, Smith AG, Backonja MM, Cole SP. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial.
Objective
To determine whether repetitive and cumulative exposure to low-frequency pulsed electromagnetic fields (PEMF) targeting painful feet can reduce neuropathic pain (NP), influence sleep in symptomatic diabetic peripheral neuropathy (DPN), and influence nerve regeneration.
Design
Randomized, double-blind, placebo-controlled parallel study.
Setting
Sixteen academic and clinical sites in 13 states.
Participants
Subjects (N=225) with DPN stage II or III were randomly assigned to use identical devices generating PEMF or sham (placebo) 2 h/d to feet for 3 months.
Interventions
Nerve conduction testing was performed serially.
Main Outcome Measures
Pain reduction scores using a visual analog scale (VAS), the Neuropathy Pain Scale (NPS), and the Patient's Global Impression of Change (PGIC). A subset of subjects underwent serial 3-mm punch skin biopsies from 3 standard lower limb sites for epidermal nerve fiber density (ENFD) quantification.
Results
Subjects (N=225) were randomized with a dropout rate of 13.8%. There was a trend toward reductions in DPN symptoms on the PGIC, favoring the PEMF group (44% vs 31%; P=.04). There were no significant differences between PEMF and sham groups in the NP intensity on NPS or VAS. Twenty-seven subjects completed serial biopsies. Twenty-nine percent of PEMF subjects had an increase in distal leg ENFD of at least 0.5 SDs, while none did in the sham group (P=.04). Increases in distal thigh ENFD were significantly correlated with decreases in pain scores.
Conclusions
PEMF at this dosimetry was noneffective in reducing NP. However neurobiological effects on ENFD, PGIC and reduced itching scores suggest future studies are indicated with higher dosimetry (3000–5000 G), longer duration of exposure, and larger biopsy cohort.
Key Words: Electromagnetic fields, Rehabilitation
List of Abbreviations: DPN, diabetic peripheral neuropathy, ENFD, epidermal nerve fiber density, HbA1C, glycosylated hemoglobin, IGF-I, insulin-like growth factor I, IGF-II, insulin-like growth factor II, NGF, nerve growth factor, NP, neuropathic pain, NPS, Neuropathy Pain Scale, PEMF, pulsed electromagnetic fields, PGIC, Patient's Global Impression of Change, VAS, visual analog scale, VEGF, vascular endothelial growth factor
Supported by Nu-Magnetics, Inc, who shipped coded devices to various sites under the supervision of a statistician. Nu-Magnetics played no role in the study design, data analysis, interpretation of data, or article development.
Investigational Review Boards at Phelps Memorial Hospital, Sleepy Hollow, NY, and each participating clinical site approved the study protocol and informed consent forms. The clinical trial was preregistered at www.clinicaltrials.gov (NCT 00123136).
No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.
Reprints are not available from the author.
PII: S0003-9993(09)00217-2
doi:10.1016/j.apmr.2009.01.019
© 2009 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.
Volume 90, Issue 7 , Pages 1102-1109, July 2009
